OncoSec Medical Incorporated (NASDAQ:ONCS) is scheduled to be issuing its quarterly earnings data before the market opens on Wednesday, October 11th. Analysts expect the company to announce earnings of ($0.24) per share for the quarter.
OncoSec Medical Incorporated (NASDAQ:ONCS) opened at 1.04 on Monday. The company has a 50-day moving average of $0.98 and a 200-day moving average of $1.08. OncoSec Medical Incorporated has a 52 week low of $0.88 and a 52 week high of $2.08. The company’s market cap is $22.01 million.
ONCS has been the subject of several research reports. HC Wainwright set a $6.00 target price on shares of OncoSec Medical and gave the company a “buy” rating in a report on Monday, June 12th. Noble Financial reissued a “buy” rating on shares of OncoSec Medical in a research report on Wednesday, June 14th. Dawson James reissued a “buy” rating and issued a $5.00 price target on shares of OncoSec Medical in a research report on Thursday, July 6th. ValuEngine raised shares of OncoSec Medical from a “strong sell” rating to a “sell” rating in a research report on Friday, July 14th. Finally, Maxim Group reissued a “buy” rating and issued a $5.00 price target on shares of OncoSec Medical in a research report on Friday, September 1st. One investment analyst has rated the stock with a sell rating and five have issued a buy rating to the company. OncoSec Medical has an average rating of “Buy” and a consensus price target of $5.33.
About OncoSec Medical
OncoSec Medical Incorporated is a biotechnology company. The Company is focused on designing, developing and commercializing gene therapies, therapeutics and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The Company’s lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation.
Receive News & Ratings for OncoSec Medical Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OncoSec Medical Incorporated and related companies with our FREE daily email newsletter.